A Study to Evaluate Chronic Hepatitis C Infection

NCT01716585 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

636

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG: ABT-450/r/ABT-267, ABT-333
DRUG: Ribavirin
DRUG: Placebo for ABT-450/r/ABT-267
DRUG: Placebo for ABT-333
DRUG: Placebo for ribavirin

Sponsor

AbbVie (prior sponsor, Abbott)